bromocriptine mesylate

FDA Drug Profile — Bromocriptine Mesylate, CYCLOSET

bromocriptine mesylate is listed in the FDA National Drug Code directory with 2 NDC codes, marketed under brand names including Bromocriptine Mesylate, CYCLOSET. Available dosage forms: capsule, tablet.

Drug details

Generic Name
bromocriptine mesylate
Brand Names
Bromocriptine Mesylate, CYCLOSET
Application Number
ANDA077226
Sponsor
Mylan Pharmaceuticals Inc.
NDC Codes
2
Dosage Forms
CAPSULE, TABLET
Routes
ORAL
Active Ingredients
BROMOCRIPTINE MESYLATE

Indications and Usage

1 INDICATIONS AND USAGE Bromocriptine mesylate is an ergot derivative indicated for the treatment of: Hyperprolactinemia-associated dysfunction including amenorrhea with or without galactorrhea, infertility, or hypogonadism in adults ( 1.1 ) Prolactin-secreting adenomas in adults and pediatric patients 11 years of age and older ( 1.2 ). Acromegaly in adults ( 1.3 ). Signs and symptoms of idiopathic Parkinson's disease or postencephalitic parkinsonism in adults ( 1.4 ). Limitations of Use Avoid use of bromocriptine mesylate capsule for the inhibition or suppression of postpartum physiologic lactation because of the risk of serious adverse reactions ( 1.1 , 5.4 ) 1.1 Hyperprolactinemia-Associated Dysfunction Bromocriptine mesylate capsules are indicated for the treatment of hyperprolactinemia-associated dysfunction including amenorrhea with or without galactorrhea, infertility or hypogonadism in adults. Limitations of Use Avoid use of bromocriptine mesylate for the inhibition or suppression of postpartum physiologic lactation because of the risk of serious adverse reactions [see Warnings and Precautions ( 5.4 )]. 1.2 Prolactin-Secreting Adenomas Bromocriptine mesylate capsules are indicated for the treatment of prolactin-secreting adenomas in adults and pediatric patients 11 years of age and older. 1.3 Acromegaly Bromocriptine mesylate capsules are indicated for the treatment of acromegaly in adults. 1.4 Idiopathic Parkinson’s Disease or Postencephalitic Parkinsonism Bromocriptine mesylate capsules are indicated for the treatment of the signs and symptoms of idiopathic Parkinson's disease or postencephalitic parkinsonism in adults.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.